2016-03-05T00:00:00.000-05:00
Ghost Tree Capital,0.339481
small molecule drugs,-0.637748
product candidates,0.476323
Tree Capital LLC,0.339481
Director Donald J.,-0.217858
clinical stage biotechnology,-0.38639
stage biotechnology company,-0.38639
clinical trials,-0.726983
Co. Inc.,0.469429
chief executive officer,0.233623
acute coronary syndrome,-0.70846
consensus price target,0.517639
InvestorPlace Broker Center,0.555736
Vitae Pharmaceuticals,0.130406
multiple disease areas,-0.707978
12-month high,-0.264134
personal trading style,0.598412
Zacks Investment Research,0.319993
Millennium Management LLC,0.36872
D. E. Shaw,0.469429
Pharmaceuticals Inc Daily,0.429096
Candriam Luxembourg S.C.A.,0.298168
Boxer Capital LLC,0.258552
unmet medical needs,-0.625627
average price,0.00539511
shares,0.0991743
Alzheimer’s disease,-0.726983
concise daily summary,0.513846
MarketBeat reports,-0.286175
stock broker,0.245696
clinical trial,-0.427227
consensus rating,0.412015
autoimmune disorders,-0.807634
rating,0.412015
quarter,0.0501468
new stake,0.27836
